T

The Parliamentary Under-Secretary of State, Department of Health and Social Care (Baroness Merron) (Lab)

Speaking in the House of Lords on 22 October 2026

Debate

Hormone Replacement Therapy: Product Shortage

Contribution

My Lords, most of the 70 HRT products available in the UK remain in good supply; three are currently affected and alternative products are available. To mitigate any impact on patients, we have expedited deliveries, issued comprehensive NHS guidance and introduced serious shortage protocols to allow pharmacists to supply alternative brands without the need to return to prescribers. We continue to work with suppliers, regulators and importers.

More from The Parliamentary Under-Secretary of State, Department of Health and Social Care (Baroness Merron) (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.